European Medicines Agency’s privacy statement for the operation of video-surveillance (CCTV) system
European Medicines Agency’s privacy statement for the operation of video-surveillance (CCTV) system
European Medicines Agency’s privacy statement for the operation of video-surveillance (CCTV) system
Record of data processing activity relating to Security Access Control System (public)
Record of data processing activity relating to the filemaker security database for staff vehicles/bicycles and lost/found property (public)
List of substances and products subject to worksharing for signal management
Funding
Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 26, Status: Authorised
Brexit-related guidance for companies
Questions and answers to stakeholders on the implications of Regulation (EU) 2023/1182 for centrally authorised medicinal products for human use
List of signals discussed at PRAC since September 2012
New product information wording – Extracts from PRAC recommendations on signals adopted at the 27-30 November 2023 PRAC